Globus Medical has been actively pursuing growth through strategic acquisitions and product innovation. The company’s recent acquisition of Nevro Corp for $250 million represents a significant ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

Across the recent three months, 4 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. In the table below ...

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

As the medical device industry transitions to a highly consumer-driven marketplace, incorporating user feedback into new ...

In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire ...

They are also catalysts for innovation, as the collaboration of individuals with varied perspectives often yields creative solutions to complex medical problems. This innovation is crucial for ...